101 – 110 of 119
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 1999
-
Mark
Localization of protein gene product 9.5 immunoreactivity in derivatives of the human Wolffian duct and in prostate cancer
(
- Contribution to journal › Article
- 1998
-
Mark
Forskningsframsteg om hereditär prostatacancer. Riskfamiljer bör kartläggas och erbjudas screening
(
- Contribution to journal › Article
-
Mark
Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum
(
- Contribution to journal › Article
- 1996
-
Mark
Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer
(
- Contribution to journal › Article
- 1995
-
Mark
Free, Complexed and Total Serum Prostate Specific Antigen : The Establishment of Appropriate Reference Ranges for their Concentrations and Ratios
(
- Contribution to journal › Article
- 1994
-
Mark
Alpha 1-antichymotrypsin production in PSA-producing cells is common in prostate cancer but rare in benign prostatic hyperplasia
(
- Contribution to journal › Article
- 1993
-
Mark
Production of alpha-1-antichymotrypsin by PSA-containing cells of human prostate epithelium
(
- Contribution to journal › Article
- 1992
-
Mark
Protein C inhibitor in human body fluids. Seminal plasma is rich in inhibitor antigen deriving from cells throughout the male reproductive system
(
- Contribution to journal › Article
-
Mark
Prostate specific antigen predominantly forms a complex with alpha1‐antichymotrypsin in blood. Implications for procedures to measure prostate specific antigen in serum
(
- Contribution to journal › Article
- 1990
-
Mark
Three predominant prostatic proteins : Drei vorherrschende Prostataproteine
(
- Contribution to journal › Article